Bill Sponsor
Senate Bill 3565
115th Congress(2017-2018)
Opioid Advocacy Transparency Act of 2018
Introduced
Introduced
Introduced in Senate on Oct 10, 2018
Overview
Text
Introduced
Oct 10, 2018
Latest Action
Oct 10, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3565
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Missouri
Republican
Louisiana
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Opioid Advocacy Transparency Act of 2018

This bill expands reporting requirements related to the ownership and investment interests of certain patient-advocacy organizations.

Under current law, a manufacturer of drugs, devices, or medical supplies that are covered under Medicaid or Medicare must regularly report on any payment or transfer of value by the manufacturer to a "covered recipient," defined as either a physician who is not an employee of the manufacturer or a teaching hospital. The bill expands the definition of "covered recipient," for purposes of this requirement, to also include patient-advocacy organizations that advocate on issues related to opioids. Furthermore, with respect to transfers of value to such organizations, the bill subjects not only manufacturers but also pharmaceutical trade associations to the reporting requirement.

Text (1)
October 10, 2018
Actions (2)
10/10/2018
Read twice and referred to the Committee on Finance.
10/10/2018
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:41:09 PM